364 related articles for article (PubMed ID: 31898802)
1. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo.
Naseri Z; Oskuee RK; Jaafari MR; Forouzandeh Moghadam M
Int J Nanomedicine; 2018; 13():7727-7747. PubMed ID: 30538455
[TBL] [Abstract][Full Text] [Related]
3. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
[TBL] [Abstract][Full Text] [Related]
5. Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis.
Sheykhhasan M; Kalhor N; Sheikholeslami A; Dolati M; Amini E; Fazaeli H
Biomed Res Int; 2021; 2021():5516078. PubMed ID: 34307654
[TBL] [Abstract][Full Text] [Related]
6. Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration.
Xie C; Du LY; Guo F; Li X; Cheng B
Mol Cell Biochem; 2019 Aug; 458(1-2):11-26. PubMed ID: 31165315
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases.
Zhu L; Shi Y; Liu L; Wang H; Shen P; Yang H
Cell Cycle; 2020 Jul; 19(14):1727-1739. PubMed ID: 32635856
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p.
Li H; Li F
Br J Cancer; 2018 Sep; 119(6):744-755. PubMed ID: 30220706
[TBL] [Abstract][Full Text] [Related]
10. Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.
Ding Y; Mei W; Zheng Z; Cao F; Liang K; Jia Y; Wang Y; Liu D; Li J; Li F
Tissue Cell; 2021 Dec; 73():101623. PubMed ID: 34543801
[TBL] [Abstract][Full Text] [Related]
11. Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN.
Wang B; Wu ZH; Lou PY; Chai C; Han SY; Ning JF; Li M
Cell Oncol (Dordr); 2019 Dec; 42(6):783-799. PubMed ID: 31332647
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.
Zhu LP; Tian T; Wang JY; He JN; Chen T; Pan M; Xu L; Zhang HX; Qiu XT; Li CC; Wang KK; Shen H; Zhang GG; Bai YP
Theranostics; 2018; 8(22):6163-6177. PubMed ID: 30613290
[TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from miR-34a-overexpressing mesenchymal stem cells inhibit in vitro tumor growth: A new approach for drug delivery.
Vakhshiteh F; Rahmani S; Ostad SN; Madjd Z; Dinarvand R; Atyabi F
Life Sci; 2021 Feb; 266():118871. PubMed ID: 33309716
[TBL] [Abstract][Full Text] [Related]
14. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Ono M; Kosaka N; Tominaga N; Yoshioka Y; Takeshita F; Takahashi RU; Yoshida M; Tsuda H; Tamura K; Ochiya T
Sci Signal; 2014 Jul; 7(332):ra63. PubMed ID: 24985346
[TBL] [Abstract][Full Text] [Related]
15. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3.
Yi X; Wei X; Lv H; An Y; Li L; Lu P; Yang Y; Zhang Q; Yi H; Chen G
Exp Cell Res; 2019 Oct; 383(2):111454. PubMed ID: 31170401
[TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p.
Shao M; Xu Q; Wu Z; Chen Y; Shu Y; Cao X; Chen M; Zhang B; Zhou Y; Yao R; Shi Y; Bu H
Stem Cell Res Ther; 2020 Jan; 11(1):37. PubMed ID: 31973730
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells.
Rezaei R; Baghaei K; Amani D; Piccin A; Hashemi SM; Asadzadeh Aghdaei H; Zali MR
Life Sci; 2021 Mar; 269():119035. PubMed ID: 33450254
[TBL] [Abstract][Full Text] [Related]
18. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.
Kong X; Zhang J; Li J; Shao J; Fang L
Biochem Biophys Res Commun; 2018 Jun; 501(2):486-493. PubMed ID: 29746865
[TBL] [Abstract][Full Text] [Related]
19. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p.
Zhu G; Pei L; Lin F; Yin H; Li X; He W; Liu N; Gou X
J Cell Physiol; 2019 Dec; 234(12):23736-23749. PubMed ID: 31180587
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of exosomal microRNA-224-3p derived from bone marrow-derived mesenchymal stem cells potentiates angiogenesis in traumatic osteonecrosis of the femoral head.
Xu HJ; Liao W; Liu XZ; Hu J; Zou WZ; Ning Y; Yang Y; Li ZH
FASEB J; 2019 Jul; 33(7):8055-8068. PubMed ID: 30964699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
